Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article
Open Access Highly Access

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Sacha J Howell*, Elizabeth Anderson, Tom Hunter, Gillian Farnie and Robert B Clarke

Breast Cancer Research 2008, 10:R68 doi:10.1186/bcr2129

Accesses  

  • Last 30 days: 96 accesses
  • Last 365 days: 1066 accesses
  • All time: 5423 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations